INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $8,000 | +33.3% | 2,525 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | +20.0% | 2,525 | +51.8% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 1,663 | +9.0% | 0.00% | – |
| Q1 2019 | $6,000 | 0.0% | 1,525 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -33.3% | 1,525 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | -82.7% | 1,525 | -88.5% | 0.00% | -100.0% |
| Q2 2018 | $52,000 | -16.1% | 13,258 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $62,000 | -13.9% | 13,258 | -24.8% | 0.00% | 0.0% |
| Q4 2017 | $72,000 | -12.2% | 17,634 | +35.6% | 0.00% | 0.0% |
| Q3 2017 | $82,000 | -10.9% | 13,008 | +11.4% | 0.00% | -50.0% |
| Q2 2017 | $92,000 | +16.5% | 11,675 | -1.3% | 0.00% | 0.0% |
| Q1 2017 | $79,000 | +8.2% | 11,825 | +11.8% | 0.00% | 0.0% |
| Q4 2016 | $73,000 | -38.7% | 10,575 | -16.6% | 0.00% | -33.3% |
| Q3 2016 | $119,000 | +815.4% | 12,677 | +729.6% | 0.00% | – |
| Q2 2016 | $13,000 | – | 1,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |